Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
56.93 INR | +0.05% |
|
-5.10% | +1.46% |
Valuation
Fiscal Period: März | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 51.34 | 43.7 | 66.7 | 150.9 | 218 | 240.8 |
Enterprise Value (EV) 1 | 62.36 | 73.27 | 87.79 | 167.2 | 254.1 | 295.4 |
P/E ratio | 30.2 x | 8.72 x | 7.01 x | 23.2 x | -17 x | 9.45 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 1.26 x | 0.84 x | 1.02 x | 2.39 x | 10.5 x | 2.45 x |
EV / Revenue | 1.53 x | 1.41 x | 1.35 x | 2.65 x | 12.3 x | 3 x |
EV / EBITDA | 6.55 x | 4.78 x | 3.44 x | 7.45 x | -151 x | 6.32 x |
EV / FCF | 12.4 x | - | 7.89 x | - | -17.9 x | -11.6 x |
FCF Yield | 8.04% | - | 12.7% | - | -5.6% | -8.63% |
Price to Book | 2.52 x | 1.72 x | 1.91 x | 3.7 x | 7.79 x | 4.51 x |
Nbr of stocks (in thousands) | 4,600 | 4,600 | 4,600 | 4,600 | 4,600 | 4,600 |
Reference price 2 | 11.16 | 9.500 | 14.50 | 32.80 | 47.40 | 52.35 |
Announcement Date | 18-05-30 | 19-09-06 | 20-09-05 | 21-09-02 | 22-09-03 | 23-09-02 |
Income Statement Evolution (Annual data)
Fiscal Period: März | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 40.7 | 51.88 | 65.13 | 63.09 | 20.69 | 98.42 |
EBITDA 1 | 9.52 | 15.34 | 25.54 | 22.44 | -1.683 | 46.76 |
EBIT 1 | 3.805 | 9.621 | 15.31 | 11.79 | -12.03 | 35.23 |
Operating Margin | 9.35% | 18.54% | 23.51% | 18.68% | -58.15% | 35.8% |
Earnings before Tax (EBT) 1 | 2.022 | 6.442 | 12.58 | 8.912 | -14.74 | 29.7 |
Net income 1 | 1.719 | 5.016 | 9.511 | 6.506 | -12.82 | 25.48 |
Net margin | 4.22% | 9.67% | 14.6% | 10.31% | -61.97% | 25.9% |
EPS 2 | 0.3700 | 1.090 | 2.068 | 1.414 | -2.790 | 5.540 |
Free Cash Flow 1 | 5.015 | - | 11.13 | - | -14.22 | -25.5 |
FCF margin | 12.32% | - | 17.09% | - | -68.73% | -25.92% |
FCF Conversion (EBITDA) | 52.67% | - | 43.58% | - | - | - |
FCF Conversion (Net income) | 291.74% | - | 117.02% | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 18-05-30 | 19-09-06 | 20-09-05 | 21-09-02 | 22-09-03 | 23-09-02 |
Balance Sheet Analysis
Fiscal Period: März | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 11 | 29.6 | 21.1 | 16.3 | 36.1 | 54.6 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 1.158 x | 1.928 x | 0.8258 x | 0.7262 x | -21.42 x | 1.167 x |
Free Cash Flow 1 | 5.01 | - | 11.1 | - | -14.2 | -25.5 |
ROE (net income / shareholders' equity) | 8.83% | 21.9% | 31.5% | 17.2% | -37.3% | 62.6% |
ROA (Net income/ Total Assets) | 4.49% | 8.79% | 13.2% | 10.6% | -8.58% | 20.2% |
Assets 1 | 38.28 | 57.04 | 72.13 | 61.25 | 149.5 | 126.5 |
Book Value Per Share 2 | 4.420 | 5.530 | 7.600 | 8.870 | 6.080 | 11.60 |
Cash Flow per Share 2 | 1.720 | 0.6900 | 0.7300 | 1.130 | 0.3200 | 0.5000 |
Capex 1 | 7.55 | - | 7.26 | - | 47.5 | 21.6 |
Capex / Sales | 18.55% | - | 11.14% | - | 229.81% | 21.91% |
Announcement Date | 18-05-30 | 19-09-06 | 20-09-05 | 21-09-02 | 22-09-03 | 23-09-02 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+1.46% | 3.14M | |
+2.09% | 102B | |
-10.78% | 59.2B | |
+75.24% | 48.89B | |
+5.57% | 35.03B | |
-1.58% | 30.47B | |
+1.46% | 18.26B | |
+17.54% | 17.47B | |
+6.83% | 13.62B | |
+80.76% | 13.18B |
- Stock Market
- Equities
- CAPRO6 Stock
- Financials Caprolactam Chemicals Limited